PROMerck & Co Inc
stock145.45
-0.15 (-0.10%)
Price as of 13 Oct, 12:31 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Attractive
Attractive investment profile
Technical Analysis
Short-Term Outlook
Bearish
0 bull · 3 bear · 2 neutral
Medium-Term Outlook
Bearish
1 bull · 3 bear · 0 neutral
Price below 50-day MA
Price above 200-day MA
Price below 12-day EMA
Price below 26-day EMA
Neutral momentum zone
MACD below signal line
%K below %D
Price near middle band
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
-0.15
Market Cap
255B
Exchange
NYSE
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Merck & Co Inc
What is Merck & Co Inc?
Merck & Co. Inc. is a global healthcare company that focuses on developing and manufacturing medicines, vaccines, and animal health products. It is widely recognized for its research into oncology, infectious diseases, and cardiovascular health. The company generates revenue by bringing patented pharmaceuticals to market and selling them to healthcare providers and governments worldwide.
Is Merck & Co Inc a good investment?
Merck is often favored by investors for its strong dividend history and steady demand for essential medical treatments, particularly its flagship cancer drug, Keytruda. However, investors should be aware of the risks related to patent cliffs, high research costs, and the outcomes of clinical trials that can significantly impact the stock price. Please note that this information is for educational purposes only and does not constitute financial advice.
How do you invest in Merck & Co Inc?
You can invest in Merck by opening an account with a brokerage platform and searching for the ticker symbol MRK to buy individual shares. Alternatively, you can gain exposure to Merck indirectly by purchasing shares in pharmaceutical or healthcare-focused exchange-traded funds (ETFs) that hold the stock in their portfolios.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for MRK — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 07 Oct 2026Targets
No active targets — trend is consolidating.
Famous Investors Holding MRK
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.